信阳毛尖(00362.HK)拟成立SPAC 首次预计筹措4000万–5000万美元
格隆汇6月6日丨信阳毛尖(00362.HK)发布公告,集团正在与专业团队研究,以成立“特殊目的收购公司”(“SPAC”),并打算为SPAC进行首次公开发行,预计筹措4000万–5000万美元,目的将为并购一些有潜力的大数据及区化链项目。
公告表示,通过成立SPAC,集团可以善用资源涉猎大数据及区化链等新经济领域。配合集团位于黑河市的地理优势,包括位处高寒地带而享有的低耗能运算优势;及拥有相对稳定及电力价格优势,都可以为SPAC的收购项目提供全方位的支援,以达至最佳的协同效应和效益最大化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.